← Royalty Pharma plc RPRX
Market Price
$58.59
Market Cap
$25.97B
P/E Ratio
N/A
Revenue (FY 2025)
↑5.1% YoY
$2.38B
3-Yr CAGR: 2.1%
Net Income
↓-0.5% YoY
$1.32B
Net Margin: 55.7%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
13.6%
ROA: 6.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (RPRX)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2018 | $1,794.9M | — | $1,514.9M | $1,517.9M | — | — | — | $1,618.3M | — | — |
| FY 2019 | $1,814.3M | +1.1% | $1,545.7M | $2,461.4M | +62.2% | — | — | $1,667.2M | — | — |
| FY 2020 | $2,122.4M | +17.0% | $1,965.3M | $1,702.0M | -30.9% | — | — | $2,034.6M | — | — |
| FY 2021 | $2,289.5M | +7.9% | $2,123.3M | $1,241.2M | -27.1% | — | — | $2,017.5M | — | — |
| FY 2022 | $2,237.2M | -2.3% | $2,049.3M | $230.1M | -81.5% | — | — | $2,144.0M | — | — |
| FY 2023 | $2,354.6M | +5.2% | $2,167.4M | $1,700.1M | +639.0% | — | — | $2,987.8M | — | — |
| FY 2024 | $2,263.6M | -3.9% | $2,038.1M | $1,330.8M | -21.7% | — | — | $2,769.0M | — | — |
| FY 2025 | $2,378.2M | +5.1% | $2,070.5M | $1,324.2M | -0.5% | — | — | $2,489.8M | — | — |
Valuation
Market Price
$58.59
Market Cap
$25.97B
Enterprise Value
$33.92B
P/E Ratio
N/A
P/B Ratio
2.67
FCF Yield
N/A
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
87.06%
Operating Margin
65.58%
Net Margin
55.68%
Return on Equity (ROE)
13.63%
Return on Assets (ROA)
6.75%
Asset Turnover
0.12x
Revenue 3-Yr CAGR
2.06%
Financial Health & Liquidity
Current Ratio
0.13
Cash Ratio
11.64
Debt / Equity
0.882
Debt / Assets
0.437
Cash & Equivalents
$618.70M
Total Debt
$8.57B
Book Value / Share
$21.92
Cash Flow Efficiency
Operating Cash Flow
$2.49B
Capital Expenditures (CapEx)
N/A
Free Cash Flow
N/A
OCF / Revenue
104.69%
FCF / Revenue
N/A
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$21.92
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$19.62B
Total Liabilities
$9.91B
Stockholders' Equity
$9.71B
Current Assets
$6.89M
Current Liabilities
$53.16M